NIH-funded research R01 grant

Understanding how liver injury affects blood flow in portal hypertension

Official title: A Molecular Approach to the Pathogenesis of Portal Hypertension

Funded at Medical University of South Carolina · NIH-11031981 · Data updated 2026-11-12

This study is looking into how liver damage affects blood flow in people with portal hypertension, focusing on certain proteins that help control blood flow, so we can better understand the condition and find new ways to treat it.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startFebruary 15, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$413,771
NIH project number5R01DK113159-06
Project IDNIH-11031981 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with portal hypertension or those with liver injury-related conditions.

Less likely to help

Patients without liver disease or those not experiencing portal hypertension may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms behind portal hypertension, particularly focusing on how liver injury disrupts the balance of blood flow regulators. The team will explore the role of specific proteins that affect nitric oxide production, which is crucial for maintaining proper blood flow in the liver. By examining the interactions between these proteins and their impact on liver cells, the research aims to uncover new insights into the pathogenesis of this condition. Patients may benefit from a better understanding of how portal hypertension develops and potential new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve blood flow and reduce complications associated with portal hypertension.

How similar studies have gone: Previous research has shown promising results in understanding the molecular pathways involved in liver diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Rockey, Don C. — Medical University of South Carolina
  • Study coordinator: Rockey, Don C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.